Eunice Wang, Andrew Lane, Anthony Selwyn Stein, Sumithira Vasu, Todd Rosenblat, David Rizzieri, Marina Konopleva, John Katsetos, Alessandra Tosolini, Naveen Pemmaraju. "Favorable outcomes including post-transplant survival are seen independent of baseline skin burden in treatment-naïve patients (pts) with blastic plasmacytoid dendritic cell neoplasm (BPDCN) treated with tagraxofusp (TAG): Subgroup analysis of a pivotal Trial." Blood, 2025. doi:10.1182/blood-2025-5221